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a b s t r a c t 
Globally, chronic wounds impose a notable burden to patients and healthcare systems. Such skin wounds 
are readily subjected to bacteria that provoke inflammation and hence challenge the healing process. 
Furthermore, bacteria induce infection impeding re-epithelialization and collagen synthesis. With an esti- 
mated global market of $20.4 billion by 2021, appropriate wound dressing materials e.g. those composed 
of biopolymers originating from nature, are capable of alleviating the infection incidence and of acceler- 
ating the healing process. Particularly, biopolymeric nanofibrous dressings are biocompatible and mostly 
biodegradable and biomimic the extracellular matrix structure. Such nanofibrous dressings provide a high 
surface area and the ability to deliver antibiotics and antibacterial agents locally into the wound milieu 
to control infection. In this regard, with the dangerous evolution of antibiotic resistant bacteria, antibi- 
otic delivery systems are being gradually replaced with antibacterial biohybrid nanofibrous wound dress- 
ings. This emerging class of wound dressings comprises biopolymeric nanofibers containing antibacterial 
nanoparticles, nature-derived compounds and biofunctional agents. Here, the most recent (since 2015) 
developments of antibacterial biopolymeric nanofibrous wound dressings, particularly those made of bio- 
hybrids, are reviewed and their antibacterial efficiency is evaluated based on a comprehensive literature 
analysis. Lastly, the prospects and challenges are discussed to draw a roadmap for further progresses and 
to open up future research avenues in this area. 
Statement of Significance 
With a global market of $20.4 billion by 2021, skin wound dressings are a crucial segment of the wound 
care industry. As an advanced class of bioactive wound dressing materials, natural polymeric nanofibers 
loaded with antibacterial agents, e.g. antimicrobial nanoparticles/ions, nature-derived compounds and 
biofunctional agents, have shown a remarkable potential for replacement of their classic counterparts. 
Also, given the expanding concern regarding antibiotic resistant bacteria, such biohybrid nanofibrous 
wound dressings can outperform classical drug delivery systems. Here, an updated overview of the most 
recent (since 2015) developments of antibacterial biopolymeric nanofibrous wound dressings is presented. 
In this review, while discussing about the antibacterial efficiency of such systems, the prospects and chal- 
lenges are highlighted to draw a roadmap for further progresses in this area. 
© 2020 Acta Materialia Inc. Published by Elsevier Ltd. 
This is an open access article under the CC BY-NC-ND license. 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
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(. Introduction 
Globally, acute and chronic wounds, e.g. burns and diabetic ul-
ers, respectively, impose a notable burden to patients and the
ealthcare systems. In Europe, there are more than 55 million pa-
ients suffering from diabetes, thereof 8 million ones are vulnera-
le to developing a diabetic foot ulcer. As a consequence of ineffi-
ient treatment of such ulcers, annually up to 450,0 0 0 lower limb∗ Corresponding authors. 
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742-7061/© 2020 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access a
 http://creativecommons.org/licenses/by-nc-nd/4.0/ ) mputations take place that can cost as much as €2–2.5 billion [1] .
he statistic for the US indicates 6.5 million patients whose annual
reatment cost is as much as $25 billion [2] . In the case of acute
ounds, in the USA, trauma induced wounds that are the most in-
ident ones result in nearly 41 million emergency department re-
errals and 2.3 million hospital stays. This situation imposes large
elevant costs of $670 billion / year including those of health care
s well as disability [3] . To alleviate such a costly burden, there is
xtensive research in progress to develop technologies able to treat
ounds effectively in a short time. Appropriate treatment strate-
ies include use of wound dressings with a high healing rate that
an hinder infection, prevent the undesired outcomes and lead toeduction of costs. 
rticle under the CC BY-NC-ND license. 
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i  Skin wound dressings are a crucial segment of the wound care
industry and trade worldwide. The global market of these prod-
ucts is estimated to surpass $20.4 billion by 2021 from $17.0 bil-
lion in 2016, due to the rising aging population and increasing in-
cidence of chronic diseases such as diabetes [4] . The wound dress-
ings currently available in the market are typically in the form
of hydrogels, films, sponges, and foams. As a relatively new class
of wound dressing materials, nanofibers have emerged that offer
distinct advantages. Nanofibrous meshes comprising many inter-
secting nanofibers as small as a few microns to a few hundred
nanometers can provide a notably large exposed surface area and
nanoporosity, thereby facilitating interaction with the cells avail-
able in the wound bed through an extracellular matrix (ECM) mim-
icking structure [5] . 
While nanofibers can be produced via several methods such
as drawing [6] , template synthesis [7] , phase separation [8] or
self-assembly [9] , electrospinning is a superior technique due to
its simplicity, cost efficiency, and versatility [10–16] . The drawing
method, fabricating individual long nanofibers, is restricted to vis-
coelastic materials able to tolerate large deformations while re-
maining cohesive to resist against pulling stresses. Employing a
nanoporous template, the template synthesis allows for produc-
tion of solid/hollow yet discontinious individual nanofibers. More-
over, the time consuming phase separation method comprises
stages of dissolution, gelation, extraction by another solvent, freez-
ing, and drying, leading to formation of a nanoporous foam. Self-
assembly methods are also time consuming techniques wherein
single, building blocks are arranged as particular configurations to
offer desired functions [17] . 
In comparison to the golden benchmark for wound dressings
including films, foams, and microfibrous and mesh ones, nanofi-
brous dressings usually exhibit higher porosity thus allowing more
efficient permeability for water and oxygen, and superior inter-
change of nutrients as well as exclusion of metabolic wastes
[18] . Also, nanoscale fibers, conferring the dressing small inter-
stices and high surface area, can enhance hemostasis. Not only
the small pore size of nanofibrous dressings protects the wound
against bacteria infection and cell/tissue ingrowth, also advanta-
geous over the microfibrous and mesh commercial counterparts,
nanofibrous dressings can provide excellent conformability, thus a
better coverage and protection of the wounds from infection [19] .
Most significantly, compared to commercial dressings, the expan-
sive surface area of nanofibrous dressings enables efficient load-
ing/incorporation of drugs. Thus, they show a promising potential
for development of advanced, biologically active dressings. Such
capability of nanofibers has become highly attractive in the bioma-
terials sector leading to a vast research effort, as documented by
several relevant reviews in recent years [20–31] . Different to those
publications, specifically, we focus here only on biohybrid nanofi-
brous wound dressings based on biopolymers combined with an-
tibacterial agents in diverse modes. These advanced classes of an-
tibacterial nanofibrous dressings can potentially replace their es-
tablished counterparts, that are antibiotic delivery nanofibrous sys-
tems, given the expanding concern about the increase of antibi-
otic resistant bacteria. In this context, depending on the type of
the antibacterial agent incorporated, being nanoparticles, organic
macromolecules (peptides or amino acids), and nature (e.g. plant)
derived compounds, nanocomposites, biofunctionalized, and blend
systems, respectively, are introduced. As a specific highlight, in this
review we evaluate the most relevant studies published since 2015
and unravel the latest status of research in this area. 
2. Wound healing 
The proper design of a skin wound treatment strategy, includ-
ing the application of dressing systems, is intimately associatedith having vast, detailed knowledge about the wound healing
rocess and the involved factors and local conditions affecting the
ound. 
As soon as a superficial wound forms, several mechanisms start
o operate to clean up the wound milieu from the invading materi-
ls and to repair the skin primary structure. This complex healing
rocess engages diverse inflammatory cells, cytokines, chemokines,
utrients, and matrix molecules, that are released into the wound
ed. In general, wound healing comprises three principal steps
amely; inflammation, proliferation, and remodeling [32] . Fig. 1
hows the main mechanisms of wound healing and the elements
aking part in the process. The inflammatory phase commences
ight after completion of hemostasis and thereby pathogens and
oreign materials are removed from the wound milieu. To do this,
ascular permeability is provoked by vasodilation, enabling con-
entration of neutrophils and monocytes within the wound bed
32] . This step is also modulated through an intricate interplay of
ytokines, leading to transformation of monocytes to macrophages
33] . The as- differentiated macrophages play two important roles:
) phagocytosis and digestion of the tissue debris and neutrophils,
nd 2) release of cytokines and growth factors stimulating cellular
roliferation and migration. The proliferation step starts after al-
ost 3 days and based on activities of fibroblasts and generation
f ground substance and collagen. The fibroblasts present in the
rea and those derived from blood proliferate and migrate, thereby
reating the wound granulation tissue and also a new ECM. Ad-
itionally, a number of fibroblasts are converted (differentiated) to
yofibroblasts to facilitate wound closure [34] . The as-formed ECM
as a decisive effect in the modulation of cells performance dur-
ng the wound healing process [35] through molecular signaling
mainly by integrins). Later, cellular activities including prolifera-
ion, differentiation, or even apoptosis are triggered by such sig-
als [36] . Keratinocytes and fibroblasts are main skin cells that re-
ease integrins, being influenced by the ECM modulation activity
37] . Also, the ECM proteins regulate the behavior of cytokines and
rowth factors including transforming growth factor- β (TGF- β) and
latelet-derived growth factor (PDGF) released by macrophages
nd activated platelets, respectively [38 , 39] . The mentioned reg-
lative role of ECM in cellular activities is further supplemented
y its fibrous protein (made of collagens, elastin, and fibronectin)
upportive structure. Cells anchor on such a fibrous architecture,
 vascular network is formed therein, and the growth factors are
rotected against degradation [39] . During the course of the prolif-
ration phase, endothelial cells quickly grow and induce angiogen-
sis inside the granulation tissue. The transition of wound state to
 remodeling (maturation) state takes place after about 2–3 weeks
40] . The maturation of the wound tissue leads to further cross-
inking and thereby formation of normal tissue. Upon accomplish-
ent of maturation, the vascular network immediately returns to
ts former less developed state [41] . As shown in Fig. 1 , wound
ealing can be accelerated by innervation [42] . 
When an acute wound, e.g. by surgery, cut, trauma, etc., forms,
he above mentioned processes of hemostasis, inflammation, cell
roliferation, and tissue remodeling are triggered [43] . Any ab-
ormality in the healing stages can lead to chronicity or fibro-
is. Such deviation could originate from an existing disease affect-
ng e.g. blood circulation (peripheral vascular disease) and the im-
une system (immunosuppression). It could also be driven by a
etabolic disorder (e.g. diabetes), consumption of particular med-
cations, or radiation therapy [32] . In contrast to acute wounds,
hronic ones are unable to follow the physiological steps to heal
n a short period of time [34] . Chronic wounds show more no-
able protease activity, lower growth factor activity, and larger
mount of pro-inflammatory cytokines, than acute wounds do [44] .
s shown in Fig. 1 , chronic wounds can be readily subjected to
nfection and thereby show a persistent abnormal inflammation
S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 27 
Fig. 1. The healing process for acute wounds (Top) and the chronic wound biology (Bottom). EGF, epidermal growth factor; HGF, hepatocyte growth factor; FGF, fibroblast 
growth factor; KGF, keratinocyte growth factor; MSC, mesenchymal stem cell; nAG, newt anterior gradient protein. Reproduced with permission [34] . Under a CC-BY License, 
Copyright 2015, John Wiley and Sons. 
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 esponse. Re-epithelialization is inhibited while keratinocytes ex-
sting in the wound stay hyperproliferative. Moreover, an incom-
lete granulation tissue forms that does not support the healing
rocess. Such a deficiency stems from the increased density of
atrix metalloproteases (MMPs) as well as insufficient infiltra-
ion of fibroblasts. Also, neovascularization does not happen ade-
uately and fibrin cuffs hinder the available vessels to supply oxy- t  en throughout the wound, thereby causing the wound to be hy-
oxic [34] . 
. Treatment of chronic wounds 
There are two major therapeutical choices for chronic wounds
hat, however, never guarantee complete recovery. While the nega-
28 S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 
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s  tive pressure wound therapy is able to cure only very small chronic
wounds, the hyperbaric oxygen therapy could fail even after a
therapeutic period of one year [45] . In addition to such therapies,
to encourage wound healing, the use of growth factors has been
appealing and many researches have been conducted on them dur-
ing the past few decades. Yet, among the many studied growth
factors, only a few (e.g. PDGF) have shown a moderate healing ef-
ficiency in a double-blinded arbitarilly controlled study [46] . In-
fection is regarded as the most well-known barrier against wound
healing. To address such a challenge for local wound infections,
topical antimicrobials and cleansing agents have been applied since
long time ago. Despite their popularity, it has been reported that
regular application of antibiotic ointments such as those containing
gentamicin and neomycin not only does not improve the wound
status but also causes discomfort to the patient, alongside contact
dermatitis and antibiotic resistance [32] . Low concentrated formu-
lations of povidone iodine have shown optimum antimicrobial effi-
ciency for a large range of bacteria, while being nondetrimental to
cellular activities. Manuka honey in medical grade is another an-
timicrobial agent with peroxide and nonperoxide antibacterial per-
formance. This agent is able to inactivate over 50 kinds of bacteria
[47] and can be applied either as a topical preparation or as honey-
impregnated dressings [48] . 
Skin substitutes comprising a bioderived substance coupled
with a material allowing for its secure positioning within the
wound, are another option for management of chronic wounds.
However, such products can be expensive and this hinders their
extensive application. There are currently several commercial skin
substitutes based on porcine collagen or polypeptide coated mesh
materials or a porcine xenograft [32] . Another relevant option is
a skin substitute composed of newborn foreskin tissue derived fi-
broblasts, a bioresorbable polyglactin mesh, and extracellular ma-
trix. In this material, the wound healing is accelerated by the fi-
broblast performance in production of cytokines, growth factors,
collagen, and glycosaminoglycans. Such a system has proved effi-
cient for treating burn wounds and venous/pressure ulcers [49] .
However, the cost efficiency of its application is not certain yet.
One very important means in managemnet and control of chronic
wounds is the development of effective wound dressings. 
Wound dressings are made to protect the wound, remove ex-
udate, inhibit exogenous microorganism invasion and improve ap-
pearance [50] . The most promising wound dressings are biocom-
patible, enable physical protection of the wound milieu against
penetration of bacteria, are highly porous, thus air permeable, and
drive epithelization [51] . 
The first, ancient examples of wound dressing materials have
been found in the Sumerians civilization where they used poultices
of mud, milk, and plants to enable wounds to heal. The Egyptians
also created bandages made of honey plasters, plant fibers, and an-
imal fats to cover and treat wounds. In the chronological trend of
development of wound dressings, the revolutionary breakthrough
came up within the course of the 19th century with the progress
in microbiology and cellular pathology [52] . In this regard, in the
1960s it was uncovered that moisturizing a wound notably helps
it heal. This fact was based in the development of the new gener-
ation of wound dressings [52] . In addition to a moist atmosphere,
an efficient wound dressing needs to remove excessive exudates,
to supply thermal insulation, to shield the wound bed against me-
chanical trauma and bacterial invasion, to permeate gases and flu-
ids, to be peeled off with no damage to the wound, and to be safe
in terms of cytotoxicity and allergic reactions [53] . 
There are five main classes of moisture retentive wound dress-
ings including: films, foams, hydrocolloids, alginates, and hydro-
gels ( Table 1 ) [48] . The polymeric semi-permeable films (e.g. Tega-
derm) are elastic, thin, and transparent polyurethane (PU) sheets
that stick to skin using acrylic. Foams in fact comprise a hydropho-ic PU foam layer whose surface is coated by a hydrophilic ma-
erial to hinder drainage leakage and to hamper bacterial inva-
ion [48] . Foams (e.g. 3 M adhesive foam) also show an absorptive
eature and can be applied for exudative wounds [32] . Hydrocol-
oid dressings are soft and conformable and consist of an adhesive
arboxymethylcellulose, gelatin, and pectin matrix with a foam or
U film support layer. In addition to their moisture retention abil-
ty, they interact with wound exudate and create a yellow gel, fa-
ilitating autolytic debridement [48] . Hydrocolloids block air pas-
age and have a long lifespan. Yet, due to their impermeability,
hey are inefficient for exudative wounds [32] . The alginate non-
oven dressings (e.g. Algisite), whose fiber composition is derived
rom seaweed, absorb extensive amounts of fluids, thus are typ-
cally used for notably exudative wounds [32] . Alginate dressings
re able to swap calcium for sodium, thereby further absorbing ex-
date and also imparting hemostasis [48] . In relation to commer-
ial fibrous wound dressings, Mo-Sci corporation (Rolla, MO, USA)
as produced a fibrin cloth mimicking fibrous dressing made of
iodegradable borate glass fibers. The fibers that are rich of cal-
ium provoke epidermal cells migration and thus wound healing
54] . On the other hand, hydrogels are cross-linked polymeric net-
orks that can contain up to 96% water. They are applied either
s sheets or liquid gels that cover a wound or are injected into a
ound, respectively. The specific features of hydrogels are promis-
ng for dry, necrotic wounds. Particularly, they can offer a soothing
nd cooling effect and thus relieve pain [55] . 
Wound dressings are promising options for control and man-
gement of chronic wounds. With the evolution of nanotech-
ology, nanostructured dressing materials are gaining increasing
nterest and attention. Particularly, nanofibrous wound dressings
xhibiting biomimicry and other structural merits previously men-
ioned are of paramount importance. The beneficial topograph-
cal features can be supplemented with biological cues to im-
rove cellular recognition when biopolymers are used as nanofiber
aterials. 
. Biopolymeric nanofibrous wound dressings 
Taking into account the promising biocompatibility and eco-
riendliness of biopolymers, many biopolymeric nanofibers have
een studied for construction of efficient wound dressings. Orig-
nated from green, renewable resources, biopolymers, are popu-
ar for regenerative medicine. This popularity stems from their
nherent bioactivity and biodegradability and resemblance to the
CM in terms of structure and surface topography [56] . Among
he biopolymers used for wound treatment, polysaccharides are
he most studied ones. These carbohydrate polymers comprise long
olecules of monosaccharide units, successively arranged through
he glycosidic bonds. These include cellulose, hyaluronic acid,
hitin, chitosan, and alginates. This list of biopolymers is further
ompleted by addition of collagen, silk fibroin, dextran, elastin, that
ave shown applicability as biocompatible wound dressing materi-
ls [5 , 43 , 57–59] . Table 2 summarizes the main types of biopoly-
ers studied for wound healing purpose alongside their pros and
ons. 
Cellulose is a largely available polysaccharide made of glucose
hat has drawn attention for wound healing. As a wound dress-
ng for chronic wounds, it alleviates pain and accelerates the heal-
ng process. In relation to the partial- and full-thickness wounds,
ellulose dressings drive the granulation and epithelialization pro-
esses, thus assisting tissue regeneration. As an example, a wound
ressing composed of wood based nanofibrillar cellulose has been
roduced to treat burn patients [60] . This cellulose based dressing
nduces a faster epithelialization than its commercial counterpart.
ther than cellulose derived from plants, cellulose is also synthe-
ized by bacteria ( Acetobacter xylinum (Acetobacteraceae)), called
S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 29 
Table 1 
Main classes of the moisture retentive wound dressings (Reproduced with permission [48] , Copyright 2016, Elsevier). 
Wound 
dressing type 
Description Pros Cons Commercial names 
Films Elastic, thin PU layers with an acrylic 
adhesive; suitable for donor sites 
for split-thickness skin grafts 
Protect the wounds 
against invasion of 
bacteria, are gas 
permeable, and due 
to transparency 
enable visual check 
of the wound 
Insufficient removal of 
fluid, and the fluid 
drainage could be 
even destructive for 
the newly formed 
epithelium 
Tegaderm (3 M Healthcare), Polyskin II (Kendall 
Healthcare), Bioclusive (Johnson & Johnson 
Medical), Blisterfilm (The Kendall Co), Omniderm 
(Omikron Scientific Ltd), Proclude (ConvaTec), 
Mefilm (Mölnlycke Health Care), Carrafilm 
(Carrington Lab), and Transeal (DeRoyal) 
Foams Bilayer dressings comprising a 
hydrophobic PU foam surface coated 
with a hydrophilic material; suitable 
for the wounds located over bony 
areas, inside body cavities, and the 
wounds with low and moderate 
exudate production 
Moisture absorption 
and retention, blocks 
drainage leakage and 
bacterial invasion, 
and readily conforms 
with the wound area 
Possibly sticks firmly 
to the wound area in 
case of drainage 
desiccation 
Polymem (Ferris Corp), Allevyn (Smith & Nephew 
United), Biopatch (Johnson & Johnson Medical), 
Curafoam (The Kendall Co), Flexzan (Dow Hickam), 
Hydrasorb (Tyco/Kendall Co), Lyofoam (ConvaTec), 
and Mepilex (Mölnlycke Health Care) 
Hydrocolloids Pliable sheets consisting of 
water-resistant foams or gels within 
PU films; suitable for the wounds 
with poor exudate production 
Encourage formation 
of granulation tissue, 
are easy to use, and 
water-resistant 
Undergo a gelation 
process, drainage, 
and not 
recommended for 
cavities 
Duoderm (ConvaTec), NuDerm (Johnson & Johnson 
Medical), Comfeel (Coloplast Sween, Inc), Hydrocol 
(Dow Hickam), Cutinova (Smith & Nephew), 
Replicare (Smith & Nephew United), and Tegasorb 
(3 M) 
Alginates Composed of algae and kelp derived 
polysaccharides; suitable for 
exudative wounds 
Absorptive, induce 
hemostasis, and 
applicable for 
sinuses 
Not usable for dry 
wounds; necessitate 
regular dressing 
changes for the 
highly drainage 
producing wounds 
Algiderm (Bard), Algisite (Smith & Nephew), Algisorb 
(Calgon-Vestal), Algosteril (Johnson & Johnson 
Medical), Kaltostat (ConvaTec), Curasorb (The 
Kendall Co), Sorbsan (Dow Hickam), Melgisorb 
(Mölnlycke Health Care), SeaSorb (Coloplast), and 
Kalginate (DeRoyal) 
Hydrogels Hydrophilic Cross-linked polymer 
networks with high water retention 
ability; suitable for dry, necrotic 
wounds 
Enable autolytic 
debridement and 
confers a comforting 
effect for the patient 
Possible skin 
maceration 
regarding highly 
exudative wounds 
Vigilon (CR Bard), Nu-gel (Johnson & Johnson 
Medical), Tegagel (3 M), FlexiGel (Smith & Nephew), 
Curagel (The Kendall Co), Clearsite (Conmed Corp), 
Curafil (The Kendall Co), Curasol (The Kendall Co), 
Carrasyn (Carrington Laboratories), Elasto-Gel (SW 
Technologies), Hypergel (Scott Health Care), 
Normgel (SCA Hygiene Products), 2nd Skin (Spenco 
Medical, Ltd), and Transigel (Smith & Nephew) 
PU: polyurethane. 
Table 2 
Diverse biopolymers suggested for construction of wound dressings. 
Biopolymer Pros Cons Reference 
Collagen Induce native biomolecular cues correlated with cellular 
activities including adhesion, proliferation, and 
migration as well as immune reactions 
Processing stimulated denaturation, poor mechanical 
properties and high degradation rate, and possible 
prior and viral contamination in the case of the 
collagen extracted from animal tissues [56] 
[5 , 70 , 71] 
Gelatin Biocompatible and biodegradable, with low antigenicity 
[5] 
Intricate processing and harvesting [72] [73] 
Chitosan Biocompatible, negligibly toxic, structurally resembling 
natural glycosaminoglycans, and degradable by 
enzymes (chitosanase and lysozyme) [5 , 56] 
The purity, origin, and molecular weight distribution are 
crucial in process characteristics and the nanofibrous 
mesh architecture. Likely danger of disease 
transmission and antigenicity [72] 
[74] 
Fibronectin and fibrin Provokes cell adhesion and spreading, fibrin hydrogel 
shows high tissue-like water capacity, adjustable 
mechanical properties matching those of soft tissues 
[56] 
fast in vivo degradation rate and poor structural integrity 
during application [56] 
[75] 
Alginate biocompatibile, negligibly toxic, nonimmunogenic, 
inexpensive, and simply cross-linked [56] 
[76] 
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t  acterial cellulose. This type of nanostructured cellulose shows
romising physicochemical and mechanical characteristics, is bio-
ompatible and biodegradable, and has a notable hydration and
actericidal potential [59] . Mimicking the ECM structure, bacte-
ial cellulose can be widely employed for tissue engineering and
n reconstruction of damaged tissues, for wound healing as well
or blood vessel regeneration [61] . As a more sophisticated version,
ellulose dressings can be upgraded by either blending with other
iopolymers or incorporation of a wide range of active additives
ncluding enzymes, antioxidants, hormones, vitamins, and antimi-robial drugs [57] . For instance, cellulose acetate nanofibers have
een functionalized by the incorporation of gallic acid, a polyphe-
ol compound with anti-inflammatory, antibacterial, and antioxi-
ant activity and commonly found in vegetables, nuts, tea leaves,
nd fruits [62] . Such biohybrid nanofibers show an optimum bac-
ericidal effect for Staphylococcus aureus , thus high potential for
ound dressing applications. 
Hyaluronic acid (HA) is a glycosaminoglycan commonly present
n vertebrates’ conjunctive tissues, e.g. bone and skin, and is one of
he most important constituents of the ECM. In terms of composi-
30 S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 
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i  tion and structure, HA is a natural nonimmunogenic linear polysac-
charide composed of N-acetyl- d -glucosamine and glucuronic acid.
It is promptly biodegraded when used within the human body
[63] . There are several classes of HA based hydrogels proposed for
wound healing, based on glycidyl methacrylate [64] , thiol [65] , and
DNA [66] functionalized HA whose functionality promotes their
networking. As a nanofibrous wound dressing material, HA largely
absorbs exudates and supports the cellular migration and prolifer-
ation thus facilitating regeneration of the lost tissue and wound
healing [67] . Shin et al. [68] . developed a fibrous wound dress-
ing consisting of HA core- poly(lactic- co -glycolic acid, PLGA) shell
fibers loaded with epigallocatechin-3 -O- gallate (EGCG). As chal-
lenged in streptozotocin-induced diabetic rats, the HA/PLGA-E fi-
brous wound dressing accelerated the healing process of diabetic
wounds and regenerated skin. HA/poly(vinyl alcohol) (PVA) blend
nanofibers have also been produced for wound dressing [69] . In
such a system, PVA acts as the carrier polymer for HA and addi-
tionally hydroxypropyl- βcyclodextrin (HP βCD) is coupled as a sta-
bilizer for electrospinning, allowing for a water based nanofabrica-
tion process. 
Chitin and chitosan (CS) show remarkable biodegradability and
biocompatibility and are considered outstanding options for devel-
opment of wound dressings. Chitin is in fact the largest available
natural amino polysaccharide (poly-N-acetyl-glucosamine) with an
annual production volume equal to that of cellulose and typically
traced in the exoskeleton of the invertebrates, insects, and crus-
taceans as well as in the fungi cell wall [57] . Chitosan is a poly-N-
acetyl-glucosamine and consists of arbitrarily arranged β-(1 → 4)- d -
glucosamine and N -acetyl- d -glucosamine. It is derived from chitin,
through its alkaline deacetylation e.g. by exposure of shrimp shells
to NaOH. Proportional to the deacetylation extent, the properties
of chitosan differ and therefore in relation to wound healing it can
be implemented as a proliferation promoter, antibacterial agent
and macrophage activator [77] . A diverse range of formulations
based on chitosan has been suggested that mostly involves hy-
brids and composites comprising other supplementary compounds
such as sodium alginate, fibrin, pectin, epidermal growth factor
(EGF), gelatin, ciprofloxacin, cellulose, silver and ZnO nanoparti-
cles, bioactive glasses, tricalcium phosphate, thyme oil, Aloe vera,
among others [42 , 57 , 74 , 78–80] . These compositions are realized as
nanofiber, film, microbead, sponge, hydrogel, and mesh membrane
dressing systems. As antibacterial CS based nanofibrous wound
dressings, several formulations such as honey/polyvinyl alcohol
(PVA)/CS [81] , bacterial cellulose/CS/polyethylene oxide (PEO) [82] ,
PVA/CS/tetracycline hydrochloride (TCH) [42] , have been proposed.
Regarding the CS nanofibers and their biomedical applications, in-
terested reader is referred to a very recent review paper [83] . 
Alginate is a nature-derived anionic polymer that is ex-
tracted from brown seaweed and shows optimum biocompatibil-
ity and negligible toxicity and is inexpensive [84] . From chem-
istry standpoint, alginates are characterized as linear branchless
polysaccharides comprising various contents of (1 → 4 ′ )-linked β-
d -mannuronic acid and α- l -guluronic acid subunits. By tailored
processing of algae, extremely absorbing natural textures made of
calcium alginate, calcium–sodium alginate, collagen–alginate, and
gelatin–alginate are achieved that can potentially be applied as
wound dressings [57] . For wound healing application, it preserves
a proper level of moisture within the adjacent microenvironment,
notably reduces bacterial infection at the wound bed, and drives
wound healing [85] . Given the high porosity and lack of adhe-
siveness of the alginate dressings, an additional dressing seems
to be necessary for the sake of protection and stabilization [86] .
As a nanofibrous wound dressing, alginate has been blended with
synthetic polymers including PVA [87] , facilitating electrospinning,
and antibacterial agents such as honey. Proteins such as collagen, which is the largest available pro-
ein in the human body, are also commonly used to treat wounds
88] . Produced by fibroblasts, collagen promotes the cellular and
olecular cascade taking place within the course of wound heal-
ng, tissue regeneration and wound debridement [89] . Addition-
lly, providing a sacrificial material, dressings made of collagen
re able to overcome the concern of high concentration of matrix
etalloproteinases (MMPs), typically released in chronic wounds,
hat deteriorate nonviable and viable collagen of the human body
90] . Derived from animal origins of bovine, porcine, and avian,
ollagen dressings are beneficial for recovery of partial and full-
hickness wounds with a low up to average level of exudates [57] .
n this regard, Zhou et al. [58] synthesized tilapia skin extracted
ollagen nanofibers that could stimulate human keratinocyte (Ha-
aT) cell activities and epidermal differentiation, thereby accel-
rating the wound healing rate. As a conventional wound dress-
ng, collagen fibrils are coupled with other natural and synthetic
olymers to enable wound exudate absorption and preservation
f moisture to boost wound healing [3 , 91] . For instance, salmon
ilt DNA, anionic polysaccharides, minocycline based hydrogels, α-
ocopherulate, and alginic acid are some of the compounds com-
ined with collagen for the purpose of construction of wound
ressing material [57] . With an almost same composition and bi-
logical characteristics of collagen, Gelatin (GE) made through de-
aturation of collagen offers less antigenicity. Having the arginine–
lycine–aspartic acid (RGD) sequences of collagen, gelatin opti-
ally enables cell adhesion. Also, it includes high extents of
lycine, proline, and hydroxyproline that promote and expedite
ealing of damaged soft tissues and wounds [92 , 93] . Gelatin is also
ommonly hybridized with other natural additives such as alginate,
GF, and hyaluronate to realize optimum wound dressing formu-
ations [57] . A gelatin/keratin blend nanofibrous dressing was de-
eloped by Yao et al. [93] that could optimize cell proliferation,
dhesion, and migration, thus promoting wound healing and also
ascularization, as witnessed through an animal model test. 
Derived from mulberry silkworm Bombyx mori , silk fibroin (SF)
s a natural biopolymer that has been widely employed for di-
erse biomedical applications, thanks to its favorable biocompati-
ility, biodegradability, negligible inflammatory response, inexpen-
iveness and green processing [94] . In addition to such promis-
ng characteristics, due to adherence, pliability, and high exudate
bsorption capacity, SF have found application as a wound dress-
ng material. This natural polymer is processed either alone or as
 hybrid involving, e.g. chitosan, multiwalled carbon nanotubes,
lginate, etc. [57] . SF could be achieved from nonmulberry silk
erivatives such as Antheraea assama and Philosamia ricini , as well
43] . The protein sequence of this version of SF contains RGD mo-
ifs, that can ease attachment to the cells’ integrin receptors [95] .
s a result, such a feature enables optimal cell-material interac-
ions and drives the wound repair process. SF is optimally able
o mimic the skin milieu, minimize scarring and reduce atopic
ermatitis, thus supporting wound healing [96] . Such beneficial
haracteristics have encouraged researchers to develop wound
ressing systems based on SF and its derivatives [97 , 98] . Selvaraj
nd Fathima [99] fabricated antioxidant Fenugreek/SF nanofibrous
ound dressing that could induce wound healing alongside full re-
pithelialization and collagen deposition. Detailed information re-
arding SF based wound dressing are available in previously pub-
ished comprehensive reviews [100 , 101] . 
Though the biopolymeric nanofibers per se offer interesting po-
ential for wound healing, they alone are rarely able to satisfy both
oncerns of wound healing and disinfection adequately. Thus, they
ust be hybridized with functional agents that promote healing
ate and are bactericidal. Specifically, to address the challenge of
nfection in the chronic wounds, a wide range of drugs, antibacte-
S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 31 
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p  ial agents, e.g. Ag nanoparticles and herbal derivatives, e.g. honey
nd essential oils, have been hybridized with the nanofibers. 
. Antibacterial biohybrid nanofibrous wound dressings 
The wound dressings with antibacterial activity prevent wound
nfection that is indeed a barrier against normal wound healing
rocess. Typically, chronic wounds are readily subjected to bacteria
nd microorganisms that notably provoke inflammation and hence
hallenge the healing process [5] . Infection under the dressing ex-
ends the inflammation response, impedes re-epithelialization and
ollagen synthesis, and delays the healing process, thereby increas-
ng hospital stay and treatment costs [102] . Infection is caused by
he microorganisms, transferred from the hospitalized patients, in-
ernal resources and the surrounding skin [103] . Adhesion of bac-
eria onto a wound surface leads to formation of biofilms, that
re the rich bacteria containing zones, potentially shielding them
gainst the immune system and antibiotics. As a result, endotox-
ns are liberated that engender sepsis, and eventually death [104] .
hus, wounds need to be treated with wound dressings contain-
ng antibiotics and antibacterial agents to avoid bacterial infection
nd biofilm formation in the wound milieu. In this context, antibi-
tics e.g. penicillin and methicillin have been included in both skin
ounds and dressing materials [97] . Yet, evolution of antibiotic en-
uring bacteria has somehow impacted the use of traditional an-
ibiotics. For this reason, other sorts of antibacterial agents such
s quaternary ammonium compounds, metallic ions, nanoparticles,
nd antimicrobial polymers can be suggested. These classes of an-
ibacterial materials typically suffer from either insufficient effi-
iency or induction of cytotoxicity effect [97 , 105] . In the last couple
f years, a new generation of antimicrobial agents called antimi-
robial peptides (AMPs) have emerged. Such bio-derived antibiotics
re found in diverse creatures such as mammals, fishes, insects,
mphibians, and surprisingly in some bacteria, and help the host
emain immune against bacteria, fungi, or viruses [106] . Despite
aving different structures, AMPs mainly possess cationic and am-
hiphilic zones with α-helical conformation, that can potentially
amage the bacterial cell membrane [107] . AMPs are able to kill
 large range of bacteria quite promptly with a remarkable effi-
acy [108] . Moreover, AMPs have proven efficient in wound healing
hrough enhancing re-epithelialization and angiogenesis, neutraliz-
ng LPS, and immunomodulation [109 , 110] . 
While some biopolymers such as chitosan have shown inher-
nt bactericidal effect [111] , other types of polymeric wound dress-
ngs need to be equipped with antibacterial agents to minimize
he adverse effects of infection. Fig. 2 a and b schematically show a
olymeric wound dressing with antibacterial activity, that not only
hysically shields the wound against bacterial attack but also facil-
tates the migration and differentiation of fibroblasts. 
In the case of nanofibrous wound dressings, depending on the
ype of the antibacterial agent and the mode of loading on the
anofibers, several categories of antibacterial nanofibrous wound
ressings have been envisaged and studied. Other than the an-
ibacterial systems delivering drugs (drug delivery), in case the an-
ibacterial agent is incorporated into or blended with the main
iopolymer or surface resided on the biopolymer nanofibers using
 bioconnector, different classes of nanocomposite, blend and bio-
unctionalized antibacterial nanofibrous wound dressings, respec-
ively, are defined. 
.1. Antibiotic delivering antibacterial biohybrid nanofibers 
As a new generation of interactive dressings able to cure bacte-
ial infection, research has been directed towards synthesis of an-
ibiotic loaded nanofibrous dressings. Such structures enable local-
zed treatment of wounds with antibiotics and antimicrobials. Par-icularly, for chronic wounds including diabetic foot ulcers, due to
oor blood circulation at the extremities, antibiotics should be de-
ivered locally for a short time rather than via systemic administra-
ion. Thus, a topically administered drug therapy is more effective
nd selective to the wound and side effects are minimized [112] . 
With an extremely large surface area, nanofibers are promising
andidates for acting as a drug carrier. Many antibiotics and anti-
ancer drugs have been conveniently incorporated into electrospun
olymeric nanofibers for local delivery [113] . Traditionally, incor-
oration of antibiotics into nanofibers is done via blending them
nto the polymer, followed by electrospinning of the blend or by
ore-shell electrospinning wherein the antibiotic is located within
 polymeric outer shell, Fig. 3 . While in the former method, an-
ibiotics would loosely reside at the surface of the nanofibers, re-
ulting in an unwanted burst release [114] , in the latter one, in-
olving high voltage and high shearing forces imposed at the inter-
ace between core and shell fluids, proteins could be rapidly dehy-
rated and delicate bioactive agents harmed [115] . Emulsion elec-
rospinning and surface coating of the electrospun nanofibers are
wo other approaches for loading the nanofibers with antibiotics.
n the case of emulsion electrospinning, two immiscible aqueous
nd organic phases containing the antibiotic and the polymer, re-
pectively, are mixed. The resultant emulsion is subsequently elec-
rospun. The as-spun nanofibers could be either consisting of dis-
ersed zones of the inner phase across the outer phase or as core-
hell structures made via coalescence of the inner phase, leading
o formation of a continuous core. This technique has proved to be
fficient for incorporation of proteins within biodegradable poly-
ers. Yet, the likely denaturation of proteins when subjected to
rganic solvents or under the extreme conditions present within
he course of initial emulsification can be a significant shortcom-
ng [22] . Lastly, the antibiotic molecules can be adsorbed onto the
anofibers’ surface physically or chemically. This strategy typically
eeds surface modification of the nanofibers to arise the necessary
unctionality for the immobilization of the antibiotic molecules.
espite some advantages in terms of immobilization and sustained
elease of antibiotics, this approach involves several steps of chem-
cal reactions, thus it is complex, and is restricted to nanofiber
aterials that are stable in aqueous solutions [22] . Table 3 briefly
ists a number of state of the art antibiotic loaded biopolymeric
anofibers suggested for wound dressing application. 
Despite a large diversity and number of developed antibiotics,
ue to toxicity effects and challenging cellular uptake, very few of
hem have been clinically utilized. To date, the only antibiotics that
ave found application in relation to wound dressings are amino-
lycosides, beta-lactams, glycopeptides, quinolones, sulphonamides 
nd tetracyclines [21] . Such drugs fatally affect the bacterial ac-
ivity through four main mechanisms depicted in Fig. 4 a, includ-
ng disruption of bacterial cell wall biosynthesis, nucleic acid and
rotein synthesis, and also obstruction of major metabolic path-
ays [21] . As an example for the antibiotic releasing nanofibrous
ound dressings, CS nanofibers have been surface decorated with
entamicin-loaded liposome [116] . To do so, the surface of the CS
anofibers was first thiolated to enable covalent bonding with li-
osome maleimide groups, Fig. 4 b. Such a hybrid system could
how a promising bactericidal activity against E. coli, P. aeruginosa
nd S. aureus . However, the production cycle of the CS nanofibers
hrough electrospinning necessitates involvement of nonbiocom- 
atible solvents such as trifluoroacetic acid (TFA) that can
ndanger the health of the adjacent tissue [98] . In another study,
eftazidime was incorporated into the SF/GE nanofibers [123] . The
s-developed natural nanofibrous wound dressing is able to inhibit
rowth of P. aeruginosa , which is the bacterium causing infection
n over 50% of burn related wounds. Rath et al. [117] synthesized
E nanofibers containing ZnO nanoparticles and cefazolin for the
urpose of accelerating the wound healing process and prevent-
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Fig. 2. Schematic illustration of the healing trend in: a) an open wound alone and b) an open wound treated with an antimicrobial wound dressing. As seen here, the open 
wound is susceptible to invasion of bacteria, engendering delayed healing due to prolonged inflammation and large release of metalloproteinases, potentially destroying the 
ECM constituents and hindering the generation of new granulation tissue. In case of applying an antimicrobial dressing, the pathway of pathogens into the wound is blocked 
and the ones penetrated are efficiently killed. Moreover, provoking the immune system and fibroblast/keratinocyte migration, the healing pace is accelerated. c) Various 
mechanisms suggested for the killing function of antibacterial nanoparticles. Reproduced with permission [21] . Copyright 2018, Elsevier. 
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i  ing infection concurrently. Cefazolin acts as an inhibitor against
the synthesis of the bacterial cell wall through attachment to spe-
cific penicillin-binding proteins and thus confers the wound dress-
ing made of related encapsulating nanofibers with promising an-
tibacterial features. Moreover, ZnO nanoparticles steadily release
Zn cations that can largely raise re-epithelialization, lower inflam-
mation, and inhibit bacterial growth. Being a semiconductor, re-
active oxygen species (ROS) are generated by ZnO nanoparticles,
thereby optimizing cell adhesion, proliferation, and migration via
the growth factor mediated pathways. Zn as the cofactor of met-
aloprotein is vital for the regeneration of the ECM. It also performs
as a regulator in the process of auto debridement and keratinocyte
migration, two important prerequisites for wound healing. As men-ioned earlier, ZnO nanoparticles also show bactericidal potential,
hanks to their ROS generation ability that imposes oxidative stress
n proteins, DNA, and membrane structures [124] . Fig. 4 c implies
xtensive, homogenous formation of collagen in the tissues treated
ith the biohybrid nanofibers after 14 days, witnessing a notable
ound healing effect. Also, reactive cells (in dark color) and fresh
brous tissues are explicitly observed. Compared to the control
roup, the hybrid nanofibers induce formation of a larger number
f reactive cells (initial phase) and also provoke a higher fibroblast
ontent. 
In the case of the antibiotic loaded nanofibrous dressings, struc-
ural properties including nanofiber diameter play a decisive role
n the release of the antibiotic molecules. The swelling degree of
S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 33 
Fig. 3. Various adopted methods for inclusion of antibiotics into nanofibers. From top to bottom: Blend electrospinning based on co-dissolution of antibiotics and polymers in 
a common solvent; Emulsion electrospinning, based on emulsification of antibiotic solution into an immiscible polymer solution; Co-axial electrospinning, based on separate 
electrospinning of antibiotic and polymer solutions by two concentric nozzles; Surface decoration of antibiotic molecules on the nanofibers’ surface physically or chemically. 
Reproduced with permission [22] . Copyright 2017, Elsevier. 
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s  he nanofibers is dependent on the nanofiber diameter and af-
ects the release kinetics. The finer the nanofibers, the higher the
welling percentage is [117] . 
Moxifloxacin hydrochloride, that is a fourth-generation
uinolone antibiotic, is commonly employed for respiratory
nfections, community-acquired pneumonia, as well as the infec-
ions occurring in skin and soft tissues. Fu et al. [125] included
oxifloxacin hydrochloride into blend nanofibers of sodium algi-
ate/PVA to address the bacterial infection in wounds. By releasing
round 80% of moxifloxacin hydrochloride after 10 h incubation
t 37 °C, the nanofiber wound dressing enables removal of P.
eruginosa and S. aureus . Alginate fibers have also been used as a
arrier for sulfanilamide [126] . This compound is regarded as an
nexpensive antibacterial and anti-inflammatory agent, hampering
nzymatic reactions based on para-aminobenzoic acid. For such
ybrid fibrous wound dressings, a sustained and controlled drug
elease was recorded, leading to a bactericidal efficiency of 86.4%
nd 94.6% for S. aureus and E. coli , respectively. 
A wound dressing composed of nonmulberry SF nanofibers
unctionalized with EGF and ciprofloxacin HCl (CIP), has shown
esired properties such as biocompatibility, remarkable water
ptake capacity of 440%, optimum water vapor permeability
2330 g m −2 day −1 ), excellent mechanical properties ( E = 2.5 MPa)
nd also bactericidal effect [43] . In this system, while EGF provideshe necessary growth factor for wound microenvironment, CIP of-
ers an antibacterial effect. In fact, this system enjoys biomimetic
nd physicomimetic materials that provoke cell-matter interac-
ions and thereby tailor deposition of ECM and healing rate of the
ound. The nonhomogenous size distribution of the nanofibers al-
ows for biomimicry of the natural ECM, whose collagen fibrils
ize varies from 10 to 300 nm [127] . Additionally, cellular activ-
ties including migration, proliferation, and differentiation largely
epend on the mechanical properties of the dressing. The cell-
atter interactions can be tuned by the external shear stress as
ell as the mechanical signaling channels that govern the cellu-
ar behaviors [127] . Hydrophilicity and water uptake capacity are
ther important factors that can raise the wound healing efficiency.
his outcome is achieved through a short re-epithelialization time
nd proper ECM deposition, thanks to optimized cellular migra-
ion within a moist microenvironment [128] . Also, by absorption
f wound exudates and rehydration of the devitalized part of
ound tissue, moist dressings enable wound autolytic debride-
ent [128] . The architecture of the nanofibrous dressing and its
orosity are determining in water vapor permeability. A porous
ound dressing with notably large water vapor transmission rate
WVTR) (~50 0 0 g m −2 day −1 ) promptly desiccates the wound mi-
ieu and renders it necrotic. In contrast, an impermeable, occlu-
ive dressing shows a negligible WVTR (~300 g m −2 day −1 ), main-
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Table 3 
Antibiotic loaded biopolymeric nanofibers developed since 2015. 
Antibiotic Nano-fibrous 
carrier 
Antibiotic loading 
method 
Antibiotic loading 
efficiency (%) 
Target microbe Antibacterial efficiency 
(ZoI (mm) or%) 
Cell Viability ( in 
vitro ) 
Ref 
CIP PVA-SF Surface coating of the 
nanofibers 
Not reported S. aureus, S. 
epidermidis, E. 
coli, P. aeruginosa 
Promising antibacterial 
activity against all 
four tested bacteria 
Significantly high 
HDF and HaCaT 
proliferation 
[43] 
Gentamicin CS Surface coating of the 
nanofibers 
17% S. aureus, E. coli, P. 
aeruginosa 
E. coli (22 mm), S. 
aureus (23 mm) and 
P. aeruginosa 
(16 mm) 
– [116] 
Cefazolin GE Blend electrospinning 93.7 ± 1.4% S. aureus 3.4 cm – [117] 
TCH PCL-CA-dextran Blend electrospinning 1 wt% polymer 
nanofibers 
S. aureus, E. coli Promising antibacterial 
activity against both 
tested bacteria 
over 160% for 
fibroblast cells 
after 6 days 
[118] 
TCH PVA/CS Blend electrospinning 5 wt.% polymer 
nanofibers 
S. aureus, E. coli , 
and S. 
epidermidis 
8.8 ± 0.4 mm for E. 
coli , 15.6 ± 0.3 mm 
for S. epidermidis 
and 19.6 ± 0.2 mm 
for S. aureus 
90% after 3 days 
for SMCs 
[42] 
Tigecycline sericin/PVA Blend electrospinning 84.25% E. coli , and Bacillus 
subtilis 
30.13 ± 1.31 for E. coli 
and 40.51 ± 0.65 for 
Bacillus subtilis 
comparable cell 
(L929 fibroblast 
cell) activity 
with control 
[119] 
TFH PCL/GE Blend electrospinning 100% Trichophyton 
mentagrophytes, 
Aspergillus 
fumigatus and 
Candida albicans 
quite efficient in 
hindering the 
growth of 
Trichophyton 
mentagrophytes and 
Aspergillus fumigatus 
but unable to 
suppress that of 
Candida albicans 
75% cell (L929) 
viability after 2 
weeks 
[120] 
CIP EC Blend electrospinning 5 and 15 wt.% 
polymer 
nanofibers 
S. aureus, E. coli 4.29 cm for E. coli and 
4.72 cm for S. aureus 
100% cell (HDF) 
viability after 24 
h 
[121] 
Silver sulfadiazine PVP/GE Blend electrospinning 0.1, 0.2 and 
0.3 wt.% polymer 
nanofibers 
S. aureus, E. coli 4 mm for E. coli and 
3.7 mm for S. aureus 
– [122] 
∗Zone of Inhibition (ZOI); Ciprofloxacin (CIP); polyvinylalcohol (PVA); silk fibroin (SF); human dermal fibroblast (HDF); tetracycline hydrochloride (TCH); terbinafine hy- 
drochloride (TFH); ethyl cellulose (EC); chitosan (CS); gelatin (GE); polycaprolactone (PCL); cellulose acetate (CA); smooth muscle cells (SMCs); polyvinylpyrrolidone (PVP). 
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In such instances, wound healing is decelerated. An ideal wound
dressing should offer a WVTR value of 20 0 0–250 0 g m −2 day −1 
[129] . 
Despite the antibacterial effect and wound healing potential of
antibiotics, their frequent application can lead to bacterial resis-
tance. Over 70% of the bacteria engendering wound infections en-
dure in the presence of a minimum of one antibiotic being used
in medicine [21] . Additionally, there are several multidrug resis-
tant bacteria and their number is ascending considerably. This
means that bacteria are becoming resistant against many vari-
eties of natural and synthetic antibiotics and thus efficient alter-
native means must be sought promptly. In this context, biohybrid
nanofibers involving antimicrobial agents in the form of nanopar-
ticles, biofunctional ligands, antibacterial ion releasing organic or
inorganic materials, and plant-derived compounds are potential
alternatives. 
5.2. Nanocomposite antibacterial nanofibers 
Nanofibrous wound dressings with antibacterial action can
be classified as those containing antibacterial nanoparticles
(nanocomposites), functional agents (surface functionalized), and
bio-derived compounds (bioblends). Regarding the first category,
silver nanoparticles have endowed polymeric nanofibers with an
antibacterial effect [130] . .2.1. Silver nanoparticle containing nanocomposite antibacterial 
anofibers 
Silver is considered an important antibacterial agent for in-
ections occurring in burns, open wounds, and chronic ulcers. Its
ecognition for this purpose (bactericidal activity) has a long his-
ory exceeding centuries. For instance, as old as 10 0 0 BC, silver was
sed for water treatment due to its bactericidal effect [131 , 132] .
lso, over many centuries, Ag has been implemented in the treat-
ent of various diseases [133] . Tetanus and rheumatism are two
edical problems that were treated by silver in the 19th cen-
ury. Also cold and gonorrhea were cured by silver based antibac-
erial drugs in the early 20th century [131] . Silver is almost an
nert metal that is weakly absorbed by mammalian or bacterial
ells. Yet, when exposed to wound fluids, it is easily ionized and
urns to an extremely reactive agent that sticks to proteins and
ell membranes [134] . Silver ion kills microorganisms and dras-
ically damages them by poisoning the respiratory enzymes and
he microbial electron carrying sections and also by disabling var-
ous DNA activities [134] . The hindering performance of silver ion
tems from its intensive bonding ability with thiol groups avail-
ble in the cell respiratory enzymes. Moreover, silver ion is able to
nteract with the proteins constituting the cell structure and par-
icularly with DNA bases, thereby hampering replication [132] . Ac-
ording to the in vitro studies, the bactericidal effect of the silver
on is mainly ascribed to its attachment to the unoccupied sul-
hydryl groups within the bacterium or on its surface, engendering
S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 35 
Fig. 4. a) The four possible mechanisms whereby antibiotics disrupt the bacterial activities. Reproduced with permission [21] . Copyright 2018, Elsevier. b) The chemistry 
behind the liposome immobilization on the chitosan nanofibers’ surface comprising: I – the reaction between the primary amine group of chitosan and 2-iminothiolane 
(2-IT) at pH 7.27; II – emergence of surface thiol groups and their reaction with maleimide at pH 7. Reproduced with permission [116] . Copyright 2015, Elsevier. c) H&E 
staining of the tissue adjacent the control and cefazolin–ZnO nanoparticle incorporated gelatin nanofiber implies the collagen content (C) and density of the fibroblast cells 
(F). Reproduced with permission [117] . Copyright 2016, Elsevier. 
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s  assivation of the enzyme phosphomannose isomerase [135] . Ad-
itionally, accumulation of silver ion within the cell and its likely
nteraction with the cytosolic proteins, mitochondrial enzymes
nd nuclear DNA or RNA complement this bactericidal function
131 , 135] . Fig. 2 c demonstrates the underlying mechanisms for the
actericidal effect of Ag nanoparticles. 
Given the high potential of silver ion in addressing the signif-
cant challenge of wound infections, Ag nanoparticles have been
idely employed as an antibacterial filler for polymeric nanofibers
eveloped for wound dressings. In general, incorporation of Ag
anoparticles into polymeric nanofibers can be carried out in sev-
ral manners. One approach is electrospinning of a dispersion of
g nanoparticles in a polymer solution. Such method has been
lready shown to be problematic due to aggregation leading to
he loss of efficiency of the nanoparticles [14 , 15] . In contrast, for-
ation of Ag nanoparticles onto the polymeric nanofibers seems
 favorable technique in terms of preservation of the antibacte-
ial activity of the nanoparticles. In this regard, several techniques
ave shown promising applicability including sol-gel and surface
unctionalization. As the former method, inclusion of a precur-
or salt to the polymer solution to be electrospun and eventually
ydrothermal treatment of the formed nanocomposite nanofibers,
ring about homogenous surface decoration of the nanofibers by
he nanoparticles [15 , 136 , 137] . Surface functionalization by pro-eins, polydopamine, among others, could be also an effective ap-
roach to create polymeric nanofibers decorated by metal nanopar-
icles [13] . For instance, an inexpensive serum albumin protein
uch as Bovine Serum Albumin (BSA) can readily bond with the
unctional polymers, e.g. poly(acrylonitrile-c o- glycidyl methacry-
ate) (PANGMA), through an amine-epoxy reaction. This biofunc-
ionalized nanofiber system can subsequently capture noble metal
anoparticles through a metal-protein interaction when immersed
n a metal containing aqueous dispersion. Under this condition,
he protein undergoes conformational change from alpha helix to
eta sheet ( Fig. 5 a) and thereby exposes functional groups that
an capture metal nanoparticles, biomolecules, etc. ( Fig. 5 b) [13] .
he resultant nanocomposite nanofibers thus exhibit nanoparti-
les uniformly coated on the surface, Fig. 5 c. Inspired by mussel
dhesion onto diverse surfaces in nature, Fig. 5 d, polydopamine
ynthesized through self-polymerization of dopamine under alka-
ine conditions, has also offered interesting opportunities for sur-
ace functionalization [138] . This coating material is able to re-
uce metal cations through its catechol groups and form metal
anoparticles, e. g. Ag. The as-synthesized Ag nanoparticles are
nsensitive to oxidation, enabling their longstanding antimicrobial
unction [130] . One significant challenge related to polydopamine
ased coatings is the difficult control of the coating thickness and
urface morphology. This shortcoming hinders the even distribu-
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Fig. 5. a) ATR-FTIR spectra for the BSA functionalized PANGMA nanofibers in different hydration states (of dry and wet represented by the solid and dashed lines, respec- 
tively). b) Schematic illustration of the capturing process of the metal nanoparticle by the swollen functionalized nanofibers). c) SEM image shows uniform distribution of 
metal nanoparticles across the nanofibers. Reproduced with permission [13] . Copyright 2012, Wiley-VCH. d) Camera image of a mussel stuck onto a polymeric surface along 
with a simple representation of the amine and catechol groups of the dopamine building block for surface coating. Reproduced with permission [138] . Copyright 2007, Sci- 
ence AAAS. e) Antibacterial activity of Ag nanoparticle/MADO nanofibers against P. aeruginosa, S. aureus , and E. coli . The inset image compares the bactericidal activity of the 
nanocomposite nanofibers with that of the neat ones on a LB-agar plate containing P. aeruginosa f) FESEM and g) HRTEM images of the Ag nanoparticle/MADO nanofibers. 
Reproduced with permission [130] . Copyright 2015, American Chemical Society. 
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3  tion of the Ag nanoparticles due to raised surface roughness in-
duced by undesirable aggregation of polydopamine in arbitrary lo-
cations [139] . To address this concern, a mussel-inspired copoly-
mer, called poly(dopamine methacrylamide- co -methyl methacry-
late) (MADO) has been electrospun to develop nanofibers. Such
catecholic nanofibers are able to reduce and therefore form Ag
nanoparticles on the nanofiber surface [130] . Accordingly, the
nanocomposite nanofibers show promising antibacterial perfor-
mance against both Gram-negative ( Escherichia coli; E. coli ) and
Gram-positive bacteria ( S. aureus) and Pseudomonas aeruginosa (P.
aeruginosa) ), Fig. 5 e. Fig. 5 f and g exhibit the uniform arrange-
ment of Ag nanoparticles on the surface of the MADO nanofibers.
Despite various merits of such nanocomposite strategy, the rather
complex material synthesis and likely high costs involved can po-
tentially hamper large scale production of this wound dressing ma-
terial. Moreover, release and accumulation of silver, that is poten-
tially cytotoxic, in different organs could be problematic and could
induce undesirable side effects. For instance, Ag nanoparticles de-
cline the activity of mitochondrial respiratory chain complexes I,
II, III, and IV within different tissues of Wistar rats [140] . With
respect to Ag nanoparticle incorporated biopolymeric nanofibers
for wound dressing purposes, a recent study showed the use of
jelly fish as a Q-mucin glycoprotein and collagen rich component
blended with polycaprolactone (PCL) in a nanofibrous system [141] .
Fig. 6 a shows the formation process of the core (PCL)-shell (jelly
fish) fibers during electrospinning. Superior to mammalian (e.g.
bovine) derived collagen that potentially endangers the health of
recipients via transmission of bovine spongiform encephalopathy
and transmissible spongiform encephalopathy, collagens obtained
from sea creatures such as jelly fish are safe and offer different
merits. Other than collagen type I and II, the jelly fish tissue con-ains Q-mucin glycoprotein. This largely glycosylated high molecu-
ar weight nonglobular protein possesses similar structural charac-
eristics to human mucins. As a notable feature, having cysteine
mino acid, mucin proteins are able to capture MMPs and neu-
rophile elastase, which is the collagen-digesting enzyme, thereby
acilitating collagen synthesis and faster healing of wounds. To
enefit from the promising properties of the jelly fish protein for
he sake of wound healing and concurrently addressing possible
nfections, Nudelman et al. [141] developed a blend nanofiber sys-
em comprising jelly fish biomass, qmucin and PCL. This bioblend
anofiber is able to chelate Ag ions through mucin cysteine amino
cids whose electronegativity is notably lower in comparison to
hat of Ag + , engendering formation of a biohybrid nanofiber with
ntibacterial activity. Interestingly, growth of E. coli , nonpathogenic
. aureus , and methicillin-resistant S. aureus was totally inhibited
y the biohybrid nanofibers, Fig. 6 b–d. Also, as shown in Fig. 6 e
nd f, witnessed by preclinical tests based on porcine wound heal-
ng models, a prompt and efficient healing trend is achieved using
uch state of the art biodegradable nanofibers. It was reported that
he biohybrid nanofibers can induce wound epithelialization and
e-epithelialization and later formation of totally healed skin tis-
ue evidenced by the appearance of a fine and integrated epider-
al layer and new collagen fibers in the dermis layer [141] . The
uthors justify such a healing behavior induced by the biohybrid
ound dressing as: 1) there is a close, robust interface between
he nanofibers, whose large surface area is coated with collagen
nd mucin proteins, and the wound. Such an intimate interface
otably keeps away MMPs from regenerated collagen and thereby
rovokes the formation of collagen fibers in the dermis layer. 2)
ue to the presence of the Ag nanoparticles, infection is hampered.
) The ECM biomimicking structure of the jelly fish nanofibrous
S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 37 
Fig. 6. a) Synthesis procedure of jelly fish (JF)-PCL fibers. b–d) The graphs imply the bacterial growth trends. Note that the negative control is the sterile Tryptic soy (TS) 
broth alone and the positive control is the TS broth inoculated with b) E. coli , c) S. aureus , and d) Methicillin-resistant S. aureus . e) H&E staining of the wound tissue subjected 
to the jelly fish (A) and silvercell commercial wound dressing (D), over a 12 day period with intervals of 3, 6, and 9 days. Note that the arrows in different colors represent 
different processes taking place within the wound. f) The jelly fish dressings raises the recovery percentage of the wounds treated by them. Reproduced with permission 
[141] . Copyright 2019, John Wiley and Sons. 
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[  ressing encourages cellular activities and thus the healing pro-
ess. 4) Thanks to the hydrophilicity of the nanofibers, moist is
aintained and dehydration of the wound and crust formation is
voided. 
.2.2. Metal oxide nanoparticle containing nanocomposite 
ntibacterial nanofibers 
As shown in Fig. 2 c, alongside Ag nanoparticles, other types
f nanoparticles made of Fe 3 O 4 , TiO 2 and ZnO can potentially
ct as antimicrobial agents coupled with biopolymeric nanofibers.
or instance, Cai et al. [142] developed chitosan/gelatin hybrid
anofibers that were reinforced by inclusion of Fe 3 O 4 nanoparti-
les. This nanocomposite strategy led to formation of nanofibrous
ressings with high robustness and antibacterial function. How-
ver, agglomeration of the nanoparticles and their residence inside
he nanofibers are two bottlenecks that could notably challengehe antibacterial performance of such nanocomposite systems. On
he other hand, deposition of the nanoparticles on the nanofiber
urface could lead to their release into the human body and hav-
ng undesired consequences, as they can reach internal sensitive
rgans and alter cell biochemical pathways. 
TiO 2 nanoparticles also offer bactericidal activity when sub-
ected to UV irradiation. This activity can be tailored by chang-
ng the irradiation related factors including duration, intensity and
avelength, environmental parameters such as pH and tempera-
ure, dimension and morphology of the nanoparticle, oxygenation
nd hydroxylation degree, and ROS retention time [143 , 144] . It is
orthy to note that the photocatalytic antibacterial activity of TiO 2 
anoparticles can be tuned by doping with metals, metal oxides,
r nonmetals [145] . In addition to the light-driven ROS genera-
ion, TiO 2 can show antibacterial activity even in the darkness
143] . Outstanding bactericidal activity of TiO 2 nanoparticles has
38 S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 
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t  provoked a number of related researches where this property is
coupled with the biocompatibility and the extensive surface area
of biopolymer nanofibers. For instance, Woo et al. [146] fabricated
a bilayer wound dressing comprising a TiO 2 –CS nanofibrous layer
overlaid onto a human adipose-derived ECM sheet. In this system,
the hydroxyl and glucosidic groups of CS are rich in terms of elec-
tron density and can chelate titanium ions, forming a robust bond
between the nanoparticles and nanofibers. The as-developed dress-
ing not only inhibits bacterial ( E. coli and S. aureus ) growth and
infiltration but also shrinks the wound size to 17% in comparison
to 23% seen in the controls. The implementation of TiO 2 nanopar-
ticles as an antibacterial additive to polymeric nanofibrous wound
dressings has been discussed in the literature [147] . 
Zn is an important element influencing cellular activity and it
is involved in the synthesis of DNA and RNA, thus in association
with cell replication, differentiation and transcription. Zn also plays
a crucial role in relation to enzyme systems impacting cell division
and proliferation [148] . Due to their antimicrobial effect alongside
their ability to induce proliferation of fibroblasts and angiogene-
sis, ZnO nanoparticles have also found applications as nanofiller
in nanofibrous wound dressings. Ahmed et al. [79] coupled these
nanoparticles with CS/PVA nanofibers to construct a wound dress-
ing for diabetic ulcers that enabled promising antibacterial activity
against E. coli (20 mm ZoI), P. aeruginosa (21.8 mm ZoI), B. subtilis
(15.5 mm ZoI) and S. aureus (21.5 mm ZoI). Moreover, a faster heal-
ing rate was recorded for the nanocomposite nanofibers in com-
parison to the neat control ones. This behavior is attributed to
a higher ROS concentration triggered by ZnO nanoparticles, that
boosts cell migration and proliferation, thus wound healing. Re-
garding the antibacterial activity, Chen et al. [149] incorporated
ZnO nanoparticles into gelatin nanofibers to create an antibacterial
wound dressing. They ascribed the promising antibacterial perfor-
mance of the nanocomposite nanofibers to the generation of su-
peroxide radicals ( • O 2 
−) by the nanoparticles. Superoxide radicals
drastically deteriorate the bacterial cell wall, giving rise to leakage
of the cell content, thus a bactericidal effect. It is worthy to note
that UV irradiation maximizes the generation of the superoxide
radicals, thereby causing a higher level of bacterial death. While
being efficient in terms of bactericidal effect, some studies imply
also the cytotoxicity of ZnO nanoparticles. For instance, Cho et al.
[150] state that among SiO 2 , CuO, Co 3 O 4 and ZnO nanoparticles,
CuO and ZnO are the most toxic ones when tested with respect to
in vivo acute lung inflammogenicity and in vitro cytoxicity. 
Quaternary ammonium salts have exhibited extensive an-
timicrobial performance against many Gram-positive and Gram-
negative bacteria, and other microorganisms such as yeast and
fungi. In this regard, trimethoxysilylpropyl octadecyldimethyl am-
monium chloride (QAS) is a newly developed cationic antibacte-
rial agent whose chemical structure comprises a siloxane group
that is bound to quaternary ammonium through a long-chain alkyl
[151] . By interacting QAS’ siloxane group and polymer’s functional
groups (e.g. hydroxyl), nanofibrous dressings acquire antibacterial
activity. The likely antibacterial mechanism of QAS include: (i) the
electrostatic attraction of the quaternary nitrogen with positive
charge to the oppositely charged bacterial membrane, engender-
ing the membrane disintegration induced by the unequal surface
charge distribution. (ii) insertion of the hydrophobic long-chain
alkyl groups of QAS into the bacterial membrane and thereby al-
teration of its physicochemical property, triggering release of the
bacterial content [152] . In a recent study, QAS has been incorpo-
rated into PCL/GE nanofibers for wound disinfection purpose [151] .
Prior to the GE degradation, the inactivation of bacteria takes place
through their interaction with the GE component. Later, when in-
fection occurs, the bacteria release proteolytic enzymes that are
able to largely degrade GE. Induced by the matrix’ disintegration,
QAS is liberated and imposes its bactericidal effect on the avail-ble bacteria including S. aureus (Gram-positive) and P . aeruginosa
Gram-negative). Table 4 summarizes some of the recently devel-
ped nanocomposite antibacterial nanofibrous wound dressings. 
.3. Biofunctionalized antibacterial nanofibers 
The second class of antibacterial biohybrid wound dressings
eals with biopolymeric nanofibers surface functionalized with an-
imicrobial peptides and amino acids. In this regard, silk fibroin
nd chitosan are two important biopolymers that enable tethering
f antimicrobial agents through their numerous functional groups.
s the antimicrobial factor bound to nanofiber surface, AMPs have
een widely studied [3] . As mentioned earlier, AMPs have emerged
s a new generation of antimicrobial additives to wound dress-
ngs given their biocompatibility and, on the other hand, due to
he developing bacterial resistance to many antibiotics. In such
ybrid systems, the antimicrobial activity of the dressing is tai-
ored by the type of AMP and its activity when immobilized onto
he nanofiber surface. The latter factor highlights how crucial the
iofunctionalization strategy is. For the sake of AMP immobiliza-
ion, there are several approaches such as co-spinning, as well
s physical and covalent binding. In the case of co-spinning, the
ossibility of aggregation of the AMP molecules as well as the
imited range of proper co-solvents that do not damage the ac-
ivity of the AMP could be challenging. Regarding physiosorption
f the AMPs, the loose linkage between the antimicrobial agent
nd the nanofiber probably leads to the AMP fast desorption [3] .
mong the mentioned approaches, covalent immobilization offers
everal merits including negligible AMP leaching, long-term sta-
ility as well as nontoxicity [158] . There are two main methods
or rendering covalent links between AMPs and nanofibers sur-
ace, Fig. 7 , including: “graft to” and “surface initiated” ones. The
ormer technique is based on the covalent binding of the AMPs
nto the nanofiber surface. The latter one deals with polymeriza-
ion of the AMP from the initiators or spacers containing func-
ional groups that are stabilized on the nanofiber surface through
ovalent bonds. The “graft to” method involves surface functional-
zation of the nanofibers via oxidation, UV radiation, atmospheric
lasma, ozonation, among others. Such post-treatments allow for
mergence of functional groups, e.g. amines, carboxylic acids, alde-
ydes or thiols [3] . Here, the bottleneck is the steric hindrance
hich results from the attachment of first molecules, hampering
urther penetration of the next ones, thus lowering the grafting
ensity [159] . In addition, mechanical stress induced hydrolysis of
he bond between the free functional groups and AMPs could oc-
ur frequently [160] . Compared to the “graft to” method, the “sur-
ace initiated” one enables the peptides to grow at large densities
nd without steric hindrance. Despite such a merit, the technique
s complex and needs precise adjustment of the amount of ini-
iator (e.g. PEG) and substrate (nanofiber) as well as of the rad-
cal polymerization parameters. On the whole, advantageous over
ther relevant approaches, the “surface initiated” one enables a no-
able controllability of the immobilization process, thanks to di-
ect polymerization of the AMPs on the surface [158] . As a fact,
MP functionalization of the nanofibrous wound dressings is in-
eed an advanced concept that requires further strict evaluation.
uch studies should confirm the long term applicability of these
dvanced dressing materials in the control of microbial infections
ithout harming the human body’s immune system. Given the
ositive charge of AMP functionalized nanofibers, there is a pos-
ibility of adhesion of negatively charged bacteria and likely block-
ge of pores in the dressing, thus disruption of gas/nutrient ex-
hange pathways can occur. Moreover, since biopolymers per se
rigger particular biological responses, it is of importance to mini-
ize the likely overlap and inhibition of their effects and those of
he AMPs. In the case of functionalization of nanofibrous wound
S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 39 
Table 4 
Diverse antibacterial biohybrid nanofibers developed since 2015. 
Nanofiber Material Anti-microbial 
agent 
Synthesis method Target microbe Antibacterial 
efficiency (ZoI ∗
(mm) or%) 
Cell Viability ( in vitro ) 
(%) 
Wound healing 
efficiency ( in 
vivo )(%) 
Ref 
Ag/ MADO Nano-particle Electrospinning and Ag 
reduction via catechol 
redox chemistry 
P. aeruginosa, S. 
aureus, and E. 
coli 
E. coli (164%), S. 
aureus , (121%), P. 
aureginosa , 
(133%) 
85% NIH3T3-L1 
fibroblast 
92% [130] 
Fe 3 O 4 /CS/ GE Nano-particle Blend electrospinning of 
Fe 3 O 4 nanoparticles, 
chitosan, and gelatin 
E. coli and S. 
aureus 
E. coli (21 mm) S. 
aureus (20 mm) 
– – [142] 
TiO 2 /CS Nano-particle Plasma enhanced chemical 
vapor deposition of TiO 2 
nanoparticle on CS 
nanofibers 
S. aureus 11.5 mm – – [153] 
Insulin-CS/ 
PCL-collagen 
Nano-particle Blend electrospinning of 
PCL/Collagen nanofibers 
then their dip coating by 
the CS nanoparticles 
– microbial 
penetration was 
characterized 
based on BHI 
broth turbidity 
which was less 
significant for 
the 
nano-composite 
nanofibers. 
as high as the control 63.66 ± 3.03% and 
96.90 ± 1.11 at 
7 and 14 days 
after wounding 
[154] 
ZnO/GE Nano-particle Blend electrospinning of 
ZnO nanoparticles and 
gelatin 
E. coli and S. 
aureus 
promising 
antibacterial 
activity in dark 
and UV 
irradiated states 
No particular 
cytotoxicity 
– [149] 
GA/CA Bio-derived Blend electrospinning S. aureus 17.5 mm – – [62] 
MH/SF Bio-derived Blend electrospinning of 
SF, PEO and MH 
Methicillin- 
resistant 
Staphylococcus 
aureus (MRSA), 
P. aeruginosa, E. 
coli and S. aureus 
51% E. coli (29% S. 
aureus , 57% P. 
aeruginosa , and 
40% MRSA) for 
MH (70%)/SF 
L929 cells viability 
prevails that on 
control 
almost 100% after 
12 days 
[98] 
Lawsonia Inermis 
(henna)/ GE/OST 
Bio-derived Blend electrospinning of 
henna, GE, and OST 
E. coli and S. 
aureus 
% 92.21 S. aureus 
and 95.13% E. 
coli after 48 h 
enhanced fibroblast 
proliferation with 
henna addition 
73% [155] 
CN, LG and PM/ CA Bio-derived Blend electrospinning of 
cellulose acetate and the 
essential oils 
E. coli 100% E. coli NIH3T3 fibroblasts 
(after 96 h, 47% for 
CA/CN, 73% for 
CA/LG and 75% for 
CA/PM) and HaCaT 
keratinocytes (after 
96 h, 75% for CA/CN, 
90% for CA/LG and 
80% for CA/PM) 
– [156] 
Lawsone/PCL-GE Bio-derived Coaxial electrospinning of 
PCL (shell polymer) and 
lawsone-GE blend (core 
material) 
S. aureus and P. 
aeruginosa 
S. aureus 
(22.43 mm) and 
P. aeruginosa (-) 
HGF cells (for the 
nanofibers 
containing 1.5 wt.% 
lawsone) ( ≈80, 60, 
and 50% after 1, 2, 
and 3 days, 
respectively) 
100% (for the 
nanofibers 
containing 
1.5 wt.% 
lawsone) 
[157] 
Cys-KR12/SF Bio-functional SF electrospinning and 
post treatment by 
EDC/NHS and via 
thiol-maleimide click 
chemistry 
S. aureus, S. 
epidermidis, E. 
coli , and P. 
aeruginosa 
99% for S. aureus , 
and E. coli at 4 
◦C (at 37 ◦C the 
S. aureus 
bacterial 
reduction% 
declines down to 
20% over three 
weeks) 
promoted the 
proliferation and 
differentiation of 
HaCaT cells and the 
proliferation of 
NHDF cells 
– [97] 
CH-D/CH-Arg Bio-functional binding l -arginine to CH 
mediated by EDC/NHS 
that amidates the 
primary amine groups 
(glucosamine; GlcN) of 
CH. The CH-D/ 
CH-Arg-blend was 
subsequently 
electrospun. 
E. coli and S. 
aureus 
≈100% for both the 
bacteria 
100% cell viability for 
Human fibroblast 
75–80% [80] 
∗ Zone of inhibition (ZoI); cellulose acetate (CA); gallic acid (GA); poly(dopamine methacrylamide- co -methyl methacrylate) (MADO); manuka honey (MH); polyethylene ox- 
ide (PEO); oxidized starch (OST); cinnamon (CN); lemon-grass (LG); pepper-mint (PM); 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride /N-Hydroxysuccinimide 
(EDC/NHS); normal human dermal fibroblast (NHDF); chitosan (CH); deacetylated (D); arginine (Arg). 
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Fig. 7. Different strategies for covalent immobilization of AMPs onto nanofibers’ surfaces as: a) “graft to”; and b) “surface initiated” (re-drawn based on the schematic 
presented in [3] ). 
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adressings with antimicrobial peptides, the interested readers are
referred to a previous review article [3] . 
Given the optimum surface functionality of the biopolymers,
the antimicrobial agents can readily be immobilized without any
need of post treatment. For instance, there are several antibacterial
biohybrid nanofibrous dressings that have been synthesized solely
based on surface functionality of SF. Possessing a plethora of func-
tional groups including carboxyl, amine, hydroxyl, and phenol, dif-
ferent antibacterial agents can be readily loaded on SF nanofibers
[161] . For instance, antimicrobial peptides (e.g. Cys-KR12 origi-
nated from human cathelicidin peptide LL37) have been teth-
ered on SF nanofibers through a thiol-maleimide coupling method,
Fig. 8 a [97] . The biohybrid SF nanofibers notably reduced bacte-
rial growth when compared with their neat counterparts. Fig. 8 b
shows that the higher the immobilized factor amount, the larger
the antibacterial activity is. The bactericidal effect of the biofunc-
tionalized nanofibers is consistent over a long three week period,
regardless of the storing temperature, Fig. 8 c and d. FESEM im-
ages, Fig. 8 e, compare the biofilm formation on two groups of
nanofibers, the neat and the biofunctionalized ones, showing that
no biofilm appears on the latter group. One developing concern
about the cathelcidine peptide is bacterial resistance. For instance,
S. aureus bacteria are able to reduce the efficiency of such AMPs in
different ways. They can lower their surface negative charge when
covalently modifying anionic molecules (e.g. teichoic acids) or keep
the AMPs away by their pumps or via changing the fluidity of their
membrane, and enyzmatic cleavage of the AMPs using proteases
[162] . 
Chitosan is another biopolymer that is biocompatible and
biodegradable and offers remarkable antimicrobial effect against
a variety of microorganisms including fungi, bacteria, algae, andiruses [163–167] . This performance is achieved via the electro-
tatic interactions of chitosan amine groups (glucosamines) with
ositive charge and the counter-charged ones on the microorgan-
sm cell wall (e.g. peptidoglycans) [165] . As a result, permeability
f the cell wall alters, engendering internal osmotic imbalances.
uch mechanism hinders the growth of microorganisms. Also, the
ydrolysis of peptidoglycans triggered by the electrostatic interac-
ions expedites the leakage of intracellular electrolytes [21] . In-
pired by the promising antimicrobial activity of CS, a variety of
lend and functionalized CS nanofibers have been suggested. Given
he fact that electrostatic interaction enables chitosan to deacti-
ate and kill bacteria, enhancement of the number and density of
he positively charged groups can raise the bactericidal potential
f CS. In this regard, positively charged amino acids including l -
sparagine [168] , l -arginine [169] , and l -lysine have been grafted
nto CS to enlarge the density of the positive charge. For in-
tance, a wound dressing has been constructed based on deacety-
ated/arginine functionalized chitosan [80] . Having the guanidine
roup (pKa = 12.5), at physiological pH, the CS nanofibers func-
ionalized with l -arginine acquire an increased number of posi-
ively charged groups, thus show a higher bactericidal effect. Addi-
ionally, this biofunctional component confers the dressing higher
ollagen deposition ability and thereby promotes the wound heal-
ng process. 
.4. Bio-derived blend antibacterial nanofibers 
Plant-derived compounds such as essential oils and honey are
ther possible additives for biopolymeric nanofibers. Since pure
orms of these compounds are not electrospinnable, they are usu-
lly blended with synthetic or natural polymers [170] . 
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Fig. 8. a) Schematic illustration of the surface functionalization protocol of SF nanofibers by loading of Cys-KR12 mediated by EDC/NHS and via thiol-maleimide click 
chemistry. b) Antibacterial activity of neat SF nanofibers versus those surface functionalized with Cys-KR12, represented by Log(CFU/matrix) (K50, 10 0, 20 0, and 50 0 denote 
the different extents and densities of the antibacterial agent immobilized and correspond to 50, 100, 200, and 500 μg/mL Cys-KR12) ( n = 3, mean ± SD); bactericidal activity 
of the nanofibers over a three week period at (c) 4 °C and (d) 37 °C. The bacterial reduction (%) was determined versus the CFU of neat SF ( n = 3, mean ± SD). e) FESEM 
images show the surface of the nanofibers as neat (left column) and functionalized with Cys-KR12 after 24 h culture of S. aureus and E. coli . Reproduced with permission 
[97] . Copyright 2016, Elsevier. 
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h  Possessing antiviral, antioxidant, insecticidal, anticancer, anti-
llergic, anti-inflammatory, and antimicrobial properties [171] , es-
ential oils, that are plant secondary metabolites, have been com-
ined with biopolymeric nanofibers for wound dressing applica-
ion. The antibacterial effect of essential oils is related to their phe-
olic compounds, particularly thymol (THY) and carvacrol [172] .
innamaldehyde, geraniol, thymol analogues, menthol and car-
acrol are typical essential oils that have been frequently employed
or their antibacterial effect. For instance, antibacterial cellulose
anofibers have been produced by incorporation of three kinds
f essential oils, including cinnamon, lemongrass and peppermint
156] . These biohybrid nanofibers could kill E. coli , while they re-
ained biocompatible. 
Honey is an ancient (as old as 20 0 0 BCE) therapeutic nutri-
ion, that also shows remarkable antimicrobial, anti-inflammatory
nd antioxidant performance [173 , 174] . These features have been
o appealing that have justified commercialization of a variety
f honey containing wound dressings [175] . Thanks to its acidic
ature (low pH of 3.5–4), honey is able to acidify the alkaline
edium of chronic wounds, thereby stimulating wound healing.his correlation of wound healing to acidic pH of the wound bed
as been almost ignored in the development of nanofibrous wound
ressings. Therefore, such aspect needs to be addressed by carry-
ng out research on developing nanofibrous interactive dressings
hat can acidify the wound milieu and thus provoke wound heal-
ng. Manuka honey (MH) is one of eight known (studied) kinds of
oney that offers antibacterial function at an expansive concentra-
ion domain ranging from 6.25% to 50% (v/v). The bactericidal ef-
ect of honey is ascribed to its negligible water content, acidity,
nd also its antimicrobial agents including antimicrobial peptide
ee defensin-1, flavonoids, phenolic acid, and hydrogen peroxide
176] . MH notably kills bacteria even at high density colonies, usu-
lly with no cytotoxicity effect on skin cells [177] . On the other
and, honey is able to repair skin through encouraging the release
f cytokines and stimulating the immune system response tackling
nfection [178] . Hybrid MH/SF nanofibers have shown applicability
or wound healing purpose [98] . They not only increase cell growth
nd adhesion but also provide antibacterial activity, thereby accel-
rating wound healing. Very recently, Tang et al. [87] developed
oney loaded nanofibers of PVA/alginate blend for wound dress-
42 S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 
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r  ing applications. By increasing the honey content, the antioxidant
effect of the hybrid fibers raised and thus excessive generation
of ROS, which is tightly associated with wound inflammation and
chronicity, was hampered. The biohybrid dressing was proved ef-
ficient in terms of antibacterial function, biocompatibility as well
as cell viability. When the honey content was as much as 10%,
NIH/3T3 cell viability in the proximity of the biohybrid nanofibers
rised to 102.71 ± 1.31%. 
As an antibacterial agent, herbal extracts have also attracted
wide attention, thanks to their negligible side effects and inex-
pensiveness in comparison to synthetic drugs. A combination of
herbal extracts with biopolymeric nanofibers is indeed promising
for wound dressing application. In this context, astragaloside IV
loaded-SF-GE nanofibrous mats have been beneficial in terms of
cell adhesion and proliferation, raised angiogenesis, and thereby
expedited healing process with no scarring [179] . Astragaloside IV
is a bioactive saponin extracted from the dried plant roots of
the genus Astragalus. This extract is employed in traditional Chi-
nese medicine. Lawsonia Inermis L. (called as Henna), a mem-
ber of the Lythraceae family, has been applied as a herbal thera-
peutic for many centuries, thanks to its antidiabetic, antioxidant,
hepatoprotective, hypoglycemic, and anticancer characteristics. Ad-
ditionally, due to its anti-inflammatory and antibacterial effects,
this herb can be employed for treatment of burns, skin infections,
wounds and ulcers [155] . Lawsone (2–hydroxy-1, 4-naphthoquinone)
is the main coloring and bioactive component of Henna Leaves
that is used for the development of many derived therapeutics
for wound healing applications [180] . Particularly, it has been re-
ported that such compounds are able to accelerate the wound
closure process and to raise skin disintegration strength, tissue
granulation, hydroxyproline amount, and proliferation of fibrob-
lasts [181] . Despite these attractive merits, cellular activities in-
cluding migration and cell-cell communication could be challenged
due to the physical form of the henna derivatives. This barrier
hinders the long term utility of these compounds for treatment
of chronic wounds, as it reduces the healing rate and raises the
chance of wound infection. Electrospinning enables to benefit from
the promising merits of henna while offering a system that suits
the wound milieu adequately [182] . For instance, a state of the art
biohybrid nanofibrous dressing has been made from Lawsonia In-
ermis (henna) incorporated gelatin-oxidized starch nanofibers for
the purpose of curing second-degree burn wounds. Inclusion of
henna into the gelatin-oxidized starch nanofibers optimized adhe-
sion and proliferation of fibroblasts, collagen secretion, and also
antibacterial efficiency [155] . Similarly, henna has been incorpo-
rated into poly(l- lactic acid) (PLLA)-GE nanofibers to construct
wound dressings [183] . A nanofibrous dressing comprising henna
embedded CS nanofibers was developed by Yousefi et al. [180] .
The biohybrid nanofibrous dressing could show a bactericidal effect
against both Gram-positive ( S. aureus ) and Gram-negative bacte-
ria ( E. coli ) to maintain high cell viability and to accelerate wound
healing. The bactericidal effect of henna is ascribed to its exposed
hydroxyl groups. Such functionality allows for interaction of the
henna derivative with the proteins and carbohydrates composing
the cellular wall of bacteria, thereby blocking the enzyme sites and
inactivating them [184] . An improved cellular (Normal Human Fi-
broblast foreskin; NHF ) activity in terms of adhesion and prolifera-
tion was also recorded on the nanofibrous dressing containing the
henna extract. Eventually, the wound area in the presence of henna
containing nanofibers declined down to 3%, confirming the signifi-
cant impact of the dressing on the wound healing process. 
THY, as aforementioned, is an important phenolic compound of
the essential oils that can be derived from Lippia gracilis. With var-
ious beneficial antioxidant, antimicrobial, anti-inflammatory, and
antinociceptive properties, it is regarded a useful additive to
biopolymeric nanofibers for the purpose of wound dressing. Fornstance, recently, Miguel et al. [185] developed a bilayer asym-
etric membrane comprising SF/PCL nanofibers and THY-SF/HA
anofibers simulating the skin epidermis and dermis layers, re-
pectively. The as-developed membrane was optimally porous, ro-
ust, and wettable. Moreover, it encouraged fibroblast cells to
dhere and proliferate onto the structure. Fig. 9 a shows that
here was no particular cytotoxic effect on fibroblast cells by the
anofibers, including those containing THY. This finding was fur-
her verified by the determination of the cellular DNA content,
ig. 9 b. As shown in the SEM images, Fig. 9 c, compared to the con-
rol, cells favorably adhered onto the nanofiber membranes whose
opography and roughness resembled the ECM, as reflected in their
ncreased number of filopodia protrusions. The promising viability
f fibroblasts on the nanofibers is also explicitly visible on CLSM
mages, Fig. 9 d. Inclusion of THY conferred the membrane antibac-
erial activity against S. aureus and P. aeruginosa . While THY-SF/HA
anofibrous membranes reduced the bacterial growth as much as
7.42% and 58.43% for S. aureus and P. aeruginosa , respectively, the
HY free nanofibrous ones reduced this activity for as low as 4.05%
nd 3.42%, respectively, Fig. 9 e and f. Interestingly, as confirmed by
EM images, no significant biofilm formation was recorded on the
amples incorporating THY, Fig. 9 g. 
Starch is a plant-derived carbohydrate compound composed of
mylose (20–30%) and amylopectin (70–80%). Diverse merits of
his biopolymer are biocompatibility, biodegradability, nontoxicity,
arge availability and inexpensiveness, enabling large applicability
f starch for various utilities in biomedicine and wound dress-
ng [186] . Blending of starch with other biopolymers such as chi-
osan for wound healing purpose has been studied [78] . Starch
s assumed to confer chitosan nanofibers optimized bioactivity as
ell as water absorption potential. A further addition of PVA into
uch a blend can raise mechanical stability of the system via inter-
nd intra-molecular hydrogen bonding of PVA and chitosan side
hains. Accordingly, biohybrid wound dressings are able to with-
tand against the exerted stresses during wound healing in both
ry and wet states. Thanks to the co-existence of chitosan, the
mazing bactericidal effect of the dressing was confirmed in the
resence of E. coli (47–72%) and S. aureus (60–84%) bacteria. Fur-
hermore, L929 fibroblast cell viability for the nanofibrous dressing
as recorded to be as much as 68–98% after 48 h co-culturing,
itnessing promising cytocompatibility of the biohybrids. This fea-
ure was further validated by a scratch assay, showing major cover-
ge of the wound gap area induced by cell growth and migration.
espite the desirable in vitro results, results of in vivo testing are
issing for such a system. Moreover, the role of starch in the en-
ancement of biological as well as mechanical performance of the
ressing has not been highlighted. The raised mechanical proper-
ies and biological activities including cell viability and antibacte-
ial efficiency are attributed to the presence of PVA and chitosan,
espectively. 
Carica papaya is a common natural drug for treatment of di-
erse medical conditions including neurological, vascular, and der-
al diseases. A notable wound healing, minimized infection poten-
ial and low odor generation have been reported for the wounds
reated with aqueous derivative of the Carica papaya leaves [187] .
hese leaves largely contain vitamin C (Ascorbic acid), that is a co-
actor for lysine and proline hydroxylases, playing a vital role in the
ormation and endurance of collagen tertiary structure. Moreover,
nduced by the composition of Carica papaya , the genes enabling
ollagen formation are readily expressed [188] . Fig. 10 a shows
he underlying mechanism for wo und healing induced by the
omposition (particularly vitamin C) of the Carica papaya leaves.
ery recently, Ahlawat et al. [189] investigated the extract of Car-
ca papaya leaves in wound healing and blended within PVA/GE
anofibers. This biohybrid dressing showed remarkable antibacte-
ial performance against E. coli and S. aureus so that a larger in-
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Fig. 9. In vitro biocompatibility of THY-SF/HA nanofibers represented by NHDF cell viability (a) and dsDNA content (b) (number of measurements; n = 5, ∗∗∗∗p < 0.0 0 01), c) 
SEM images show the morphology of NHDF cells co-cultured with the nanofibrous samples over a 7 day period. d) Live and dead NHDF cells on the nanofibrous membranes 
represented by green (Calcein stained) and red (Propidium iodine stained) spots, respectively, in the fluorescence microscopic images. Antibacterial efficiency of the THY- 
SF/HA nanofibrous membranes against S. aureus (e) and P. aeruginosa (f) (number of measurements; n = 5, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0 0 01). g) SEM images show the extent 
of antibacterial activity of the THY-SF/HA nanofibers in comparisonn to that of the SF/HA nanofibers and the control. Reproduced with permission [185] . Copyright 2019, 
Elsevier. 
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t  ibition zone is formed on the agar plate containing the Carica
apaya /PVA/GE nanofibers compared to that with the nanofibers
ree of Carica papaya, Fig. 10 b–j . Also, as shown in Fig. 10 k, the
iohybrid nanofibers enabled 80% NIH 3T3 fibroblast cells live
djacent to the nanofibers after 24 h, implying their favorable
iocompatibility. Moreover, no particular change in cell morphol-
gy was recorded for the cells co-cultured with the biohybrid
anofibers as compared to the ones present in the control medium.
ig. 10 l–n compares the seeded cells’ morphology on the Carica
apaya /PVA/GE nanofibers with that of the cells subjected to the
VA/GE nanofibers and the nanofiber free medium after staining
ith Hoechst 33,342-Rhodamine B. Table 4 summarizes some of i  he recently developed bio-derived blend antibacterial nanofibrous
ound dressings. 
. Conclusion and outlook 
Electrospun nanofibers have shown promising potential for a
iverse range of advanced applications in environmental remedia-
ion, energy, and biomedicine. This attractive potential stems from
 number of advantages including interconnected tunable porosity,
iomimicry, and large specific surface area enabling engineering of
he surface to include a plethora of functional groups as well as
mmobilization of drug molecules. These features have drawn the
44 S. Homaeigohar and A.R. Boccaccini / Acta Biomaterialia 107 (2020) 25–49 
Fig. 10. a) Schematic illustration showing how Vitamin C present in Carica papaya leaf acts decisively in the process of wound healing. Antibacterial efficiency (CFU) of the 
Carica papaya /PVA/GE nanofibers (c and d: 10 mg and 12 mg of Carica papaya , respectively) versus that of the PVA/GE nanofibers (b) (the circles represent each bacterial 
colony). Antibacterial efficiency validated via disk diffusion assay for Carica papaya (e, h), PVA-GE nanofibers (f, i) and Carica papaya (12 mg)/PVA/GE nanofibers (g, j). The 
micrographs show the formed inhibition zone (marked by a circle) against E. coli (e–g) and S. aureus (h–j). (k) NIH 3T3 cell viability percentage when the cells are co- 
cultured with Carica papaya / PVA/GE nanofibers. Two other columns represent the PVA/GE nanofibers as well as the nanofiber free medium. Cell morphology traced by 
Hoechst 33,342 and Rhodamine B staining of the cells co-cultured for 24 h with (l) nanofiber free medium; (m) PVA/GE nanofibers; and (n) Carica papaya /PVA/GE nanofibers 
(in the fluorescence microscopy images, the yellow and blue circles represent healthy cells and cytoplasmic constriction and nuclear fragmentation, respectively). Reproduced 
with permission [189] . Copyright 2019, Elsevier. 
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 ttention of the scientific community for the purpose of develop-
ng nanofibrous biomedical devices such as wound dressings. Given
he large incidence of acute and chronic wounds across the world,
he necessity of production of nanofibrous wound dressings able to
ontrol infection by releasing bactericidal agents and to block inva-
ion of microbes is felt nowadays more than ever. Despite promis-
ng wound healing outcomes in terms of re-epithelialization, an-
iogenesis and antibacterial activity, nanofibrous wound dressings
hould be still improved in the following different aspects: 
1- Composition: In terms of chemistry and composition, biopoly-
mers that are biocompatible and induce anti-inflammatory and
antibacterial properties, thereby accelerating wound healing,
are preferred for nanofiber synthesis. Despite favorable po-
tential of interactive biopolymeric nanofibrous dressings for
wound healing, verified through many related studies, to the
best of the authors’ knowledge, there is no commercial prod-
uct of them in the market. This arises from possible com-
plications of electrospinning of biopolymers in a large scale,
and biocompatibility concerns due to the existence of impu-
rities such as cross-linkers and residual solvents in the fibers
and the likely immunogenic reactions induced by such com-
pounds. Specifically, biopolymers like chitosan and gelatine are
hardly water soluble, thus for electrospinning they need to be
dissolved in toxic, highly acidic solvents including 1,1,1,3,3,3-
hexafluoro-2-propanol and trifluoroacetic acid (TFA) [190] . To
acquire antimicrobial effect, the nanofibers should be equipped
with secondary agents (additives) such as AMPs, metallic ions
and nanoparticles, antibiotics, or plant-derived compounds, as
discussed in this article. Taking into consideration the rapid
evolution of antibiotic resistant bacteria, research is being car-
ried out to develop alternatives to conventional drug delivery
nanofibers, for example considering AMP functionalized ones.
Recalling the hazardous dissolution and release of metallic (e.g.
Ag) ions, if exceeding the WHO limits, both AMP functional-
ized nanofibers and plant-derived biohybrid nanofibers appear
to be suitable substitutes for conventional drug delivery de-
vices. However, long term in vitro and in vivo investigations of
such systems are still demanded to guarantee their efficiency
within the course of the wound healing process. To promote
the wound healing effect, supplementary compounds such as
growth factors, metallic ion delivering materials, etc. could be
also embedded into the nanofibers. Furthermore, it is known
that acidification of the wound milieu can accelerate the heal-
ing process, thus inclusion of various agents that help acidify
the wound bed is another helpful strategy. Also, from the com-
position point of view, a state of the art class of smart nanofi-
brous wound dressings can be defined as those releasing an-
timicrobial agents and drugs when subjected to different stim-
uli including pH and temperature. This class of dressings has
been rarely developed and studied and as prospective wound
healing materials they should be further considered. Lastly, syn-
thetic, industrial polymers could be also proposed for construc-
tion of wound dressings, provided that they show no toxicity
effects. Such materials are promising due to their widely known
processing methods, favorable physicochemical properties, the
possibility of integration into engineered structures, and poten-
tial for scalability. These merits can be appealing for the devel-
opment of wound dressing materials widely and economically.
However, bioinertness is indeed a challenge that can compli-
cate the removal process of the dressing upon healing of the
wound. To address this bottleneck, a surface treatment involv-
ing biodegradable materials as a coating can be a solution. 
2- Synthesis: With respect to antibacterial nanofibrous wound
dressings, many antibiotics and anticancer drugs as well as
antimicrobial agents have been conveniently incorporated intoelectrospun polymeric nanofibers for local delivery [42 , 117] .
Traditionally, incorporation of such compounds into nanofibers
is done via blending them into the polymer, followed by elec-
trospinning of the blend or core-shell electrospinning wherein
the drug/agent is located within a polymeric outer shell. In the
former method, drugs or antimicrobial materials would loosely
reside at the surface of the nanofibers, resulting in an unwanted
burst release, thus imposing cytotoxicity toward tissue cells. In
the latter one, involving high voltage and high shearing forces
exerted at the interface between core and shell fluids, pro-
teins could be rapidly dehydrated and delicate bioactive agents
harmed. Thus, there is a need to develop alternative methods
allowing for sustained delivery of antibacterial agents without
damaging them. Despite versatility of electrospinning for pro-
duction of nanofibers in different compositions and configura-
tions, creation of an effective, reliable formulation for such bio-
hybrid nanofibers is intricate. In this regard, the technique must
be widely, yet precisely understood and standardized, particu-
larly in the sophisticated versions of emulsion and coaxial elec-
trospinning. Additionally, the production level of any desired
formulation must be largely developed up to industrial scale.
Hence, the production cycle must be economical and scalable,
particularly considering the relatively low price of many avail-
able commercial wound dressings. 
3- Design and engineering: Structurally, nanofibrous dressings need
to be engineered so that either entrap bacteria or block their
pathways into the wound. Moreover, coupled with nanoparti-
cles, they can form a hierarchical nanostructure, whose nan-
otopography can potentially raise surface hydrophobicity thus
lowering the chance of bacterial adhesion. As a result, biofilm
formation and its adverse consequences can be drastically re-
duced. Moreover, nanofibrous dressings must hinder tissue in-
growth into the structure, enabling its easy and painless re-
moval while encouraging cells to adhere and proliferate. More-
over, the dressing must be sufficiently porous and permeable
to allow exchange of air and water vapor as well as nutrients
and waste. On the other hand, such extent of porosity should
not lead to loss of mechanical stability and pliability of the
dressing. Given the diverse stresses applied to the dressing de-
pending on its location and intended use duration, mechani-
cal fatigue could be a crucial consideration as well. The dress-
ing needs to adequately remove exudates, thus in addition to
porosity, surface chemistry could play a vital role. 
4- Multifunctionality: As a further necessity, the real-time moni-
toring of the wound bed conditions in terms of pH or tem-
perature is a sophisticated challenge. Such parameters poten-
tially indicate the wound healing status and they need to be
assessed precisely and in the point of care. For this purpose,
various classes of biosensors should be integrated into nanofi-
brous wound dressings and an advanced generation of smart
devices, that are able to real time sense and monitor the wound
conditions, should be developed. Accordingly, as an all in one
package, multifunctional dressings are required that can treat
various classes of chronic wounds while notably declining the
infection tendency and wound recurrence. In fact, knowledge
frontier should be pushed towards creation of dressings that
merge three crucial functions, Fig. 11: (i) stimulating the heal-
ing process through the main, relevant physiological mecha-
nisms and even by inclusion of further functionalities such as
electrical responsiveness; (ii) monitoring the wound healing
and infection indicators such as temperature, pH, and bacte-
ria; and (iii) drug delivery in a controlled manner if wound in-
fection emerges. A nanofibrous wound dressing fulfilling these
concerns guarantees not only fast healing of a wound but
also avoids infection occurrence. Moreover, the treatment cycle
and duration could be predicted and controlled over time by
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Fig. 11. Three main requirements for the next generation of nanofibrous wound 
dressings (the images have been obtained from http://www.Bing.com and are under 
Creative Commons Licence) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 providing diverse readouts by the integrated biosensor concern-
ing wound healing status, exudate amount, infection, and lifes-
pan of the dressing [5] . 
5- Testing: Alongside production, advanced testing approaches for
the developed nanofibrous systems must be designed and ver-
ified to enable reliable evaluation and prompt translation of
these devices to clinical applications. For instance, to determine
the clinical potential of such dressings, the in vitro interaction
of the nanofibers with cells must be investigated in the pres-
ence of bacteria to simulate realistically the conditions of the
wound beds. Surprisingly, almost no research in the literature
has considered this important characterization involving bac-
teria and cell co-cultures. The achieved information can shed
light on the adhesion and growth mechanisms of bacteria onto
the nanofibers, thereby enabling physically or chemically ad-
justment of their characteristics to overcome microbial chal-
lenges. Consequently, the impact of nanofibrous dressings on
dermal cells in the presence of bacteria should be largely in-
vestigated to assure applicability of the dressings in microbio-
logical environments similar to those of real wounds. Certainly,
depending on the type of wound, involving various specific bi-
ological factors, and its chronicity, in vitro tests need to be cus-
tomized. In addition to the development of advanced biologi-
cal testing, physicochemical characteristics must be investigated
under realistic conditions in terms of pH, humidity, tempera-
ture, mechanical and thermal stress magnitude and frequency
to simulate the practical situation. In this case, it is necessary
to follow the designed standards for such kind of materials to
enable comparison with the available benchmarks and to verify
their modifications. 
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